Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Work from home jobs offer flexibility and extra cash to help pay off debt. Explore opportunities that fit your schedule.
25,050 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Rumors around chip supply and product timelines can move markets quickly. This guide shows how AMD typically responds...
Walmart is more than a giant retailer. This analysis explains whether its size translates into a durable moat and wha...
When a superstar launches a first-of-its-kind anime, money talks as loudly as fans. This article breaks down the fina...
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...
Grief arrives for anyone, but when the world watches, money and plans can unravel faster than a headline. This piece ...
A leading voice in personal finance questions the premise of hitting a $1 million target by age 25, urging young adul...
Chewy, crowned america’s best brand america’s in a 2026 reputation poll, faces a sharp stock drop as brand strength f...
Investors debate whether will joby aviation stock can double in 2026 as the eVTOL pioneer nears regulatory milestones...
When a high-profile IPO opens its doors to everyday traders, the landscape for retail investors changes. This guide e...
Sandisk stock fell today after an upbeat start as investors weighed AI memory tech prospects against inflation jitter...
AppLovin is rebounding as AI ad-tech momentum returns, with analysts modeling upside to $600+ as AXON 2 expands and b...